Immunology letters
Cure8 research brief
INNATE LYMPHOID CELLS: BRIDGING BASIC BIOLOGY and DISEASE.
Research and clinical trials
Biomarkers
Clinical study
Researchers
Clinicians
Adult patients
Inflammatory bowel disease
Why This Matters
ILCs help regulate mucosal immunity and their imbalance is linked to intestinal inflammation; understanding them may point to new biomarkers and future therapies for IBD. Clinicians and researchers may find insights relevant to mechanisms behind flares and potential precision-immunotherapy targets.
Who Should Pay Attention
Researchers studying immune mechanisms or biomarkers, clinicians interested in IBD pathogenesis and emerging immunotherapies, and patients curious about basic-science advances underlying future treatments.
Study Snapshot
Story typeResearch paper
Evidence typeResearch paper
Source depthJournal abstract
What To Know
This is a review article summarizing innate lymphoid cell (ILC) biology, their roles at mucosal surfaces, and links to inflammatory diseases including IBD.
It discusses ILC subset plasticity in the intestinal mucosa, relevance to chronic inflammation, potential for use as biomarkers, and therapeutic strategies targeting ILCs (including cell-based approaches). The review is grounded in the article abstract provided and focuses on basic and translational science rather than new clinical trial results.
It highlights conceptual connections between ILC functions and IBD pathogenesis, and notes therapeutic possibilities without presenting trial outcomes. Readers should view this as a state-of-the-field scientific review useful for understanding immune pathways and emerging biomarker/therapeutic ideas rather than immediate clinical guidance.
Keep In Mind
This record is a journal review (abstract provided). It summarizes current biology and translational ideas; it does not report new clinical trial results. Therapeutic strategies discussed are exploratory and should not be taken as established treatments.
Source Details
Review the original publication for the complete reporting, methods, and context.
Research paper
Evidence type derived from source or registry metadata.
PublicationImmunology letters
AuthorsMetin Yusuf Gelmez, Fatma Betul Oktelik, Aysenur Kokoglu +3 more
InstitutionIstanbul University, Aziz Sancar Institute of Experimental Medicine, Department of Immunology, Istanbul, Türkiye.
Study typeJournal article, review
Indexed viaPubMed
Source typeResearch paper
PublishedAug 10, 2026, 12:00 AM
Content availableJournal abstract
Conflict statement: Declaration of competing interest The authors declare that they have no known competing financial interests or personal relationships that could have appeared to influence the work reported in this paper.
This Cure8 brief is based on source text from the linked article. Cure8 is informational only and is not a substitute for professional medical advice, diagnosis, or treatment.
Immune Repertoire Profiling Reveals Distinct Adaptive Immune Signatures of Dampness ZHENG Across Psoriasis, Rheumatoid Arthritis and Ulcerative Colitis
This study suggests that subgrouping autoimmune diseases by a Traditional Chinese Medicine phenotype (Dampness ZHENG) corresponds to distinct T‑ and B‑cell receptor patterns.
Mobius Care Receives Funding from Crohn's & Colitis Foundation
A validated AI biomarker that predicts which IBD treatments are likely to work could reduce trial-and-error in treatment choices, potentially shortening time to effective therapy for people with Crohn's disease or...
New Model Predicts Crohn’s Disease Risk in Relatives
This model aims to identify healthy first‑degree relatives at higher risk of developing Crohn’s disease before symptoms start, which could enable earlier monitoring or preventive strategies. The score uses simple...